glp 1 with cv benefit Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology Stopping GLP-1s Increases Risk of

PSD95 immunoreactivity is undetectable in the intestinal mucosa PSD-95, recognized as one of the most specific and commonly used histological markers of synapses 68,69 , was investigated using a well-validated antibody in the lower intestines of WT mice

Aqu te presento algunos de los ms importantes: Control del azcar en sangre: * Aumentan la liberacin de insulina: Cuando los niveles de glucosa en sangre aumentan despus de comer, los GLP-1 estimulan al pncreas para que produzca ms insulina, lo que ayuda a reducir el azcar en la sangre

Side effects are rare overall

Involvement of a postsynaptic protein kinase A substrate in the expression of homosynaptic long-term depression